Results 211 to 220 of about 4,804,665 (363)

A targeted antiferromagnetic nanoprobe for ultra‐sensitive magnetic resonance imaging detection of sub‐millimeter esophageal tumors

BMEMat, EarlyView.
We developed a cyclo‐RGD peptide‐conjugated antiferromagnetic nanoparticle (RANP) as a targeted T1 contrast agent. Under 9 T MRI conditions, RANP exhibited an r1 value of 1.88 mM−1 s−1 and a low r2/r1 ratio of 1.84, enabling the detection of esophageal tumors as small as 0.8 mm in vivo. Abstract Early, non‐invasive detection of esophageal cancer at sub‐
Wenkui Mo, Zeyu Liang, Bo Zhang, Lin Xiao, Xun Liu, Zhigao Yi, Shangzhi Xie, Qiyue Wang, Liang Shi, Taobo Luo, Feng Li, Leilei Wu, Yuanzhe Piao, Fangyuan Li, Jian Zeng, Daishun Ling   +15 more
wiley   +1 more source

Tailoring treatment for esophageal cancer: a retrospective comparison of chemoradiation with and without esophagectomy. [PDF]

BMC Surg
Toapichattrakul P, Santasup K, Kittirungsi K, Seemakajohn T, Kittiwan P, Chumachote A, Chakrabandhu B, Chakrabandhu S.   +7 more
europepmc   +1 more source

ENDOSCOPIC ESOPHAGEAL ENDOPROSTHESIS FOR INOPERABLE ESOPHAGEAL CANCER

, 1988
Nobuyuki Miyata, Kimio Namatame, Yoshihumi ONOMURA, M Makuuchi, Naoto HAMAI, Masahiko Ohkubo, K. Takahara, Tadaaki Ikeda, K. Suzuki, Hiroshi Takahashi, Rikiya Fujita   +10 more
openalex   +2 more sources

Lactylation in cancer biology: Unlocking new avenues for research and therapy

Cancer Communications, EarlyView.
Abstract Lactylation, a newly identified post‐translational modification, plays a multifaceted role in cancer biology by integrating epigenetic and non‐epigenetic mechanisms. This review summarizes the latest research progress on lactylation, including its functions in epigenetic regulation and its broader impact on cellular processes.
Xiaoyu Hou, Zhenya Hong, Huimin Zeng, Changyi Zhang, Peng Zhang, Ding Ma, Zhiqiang Han   +6 more
wiley   +1 more source

From endoscopy to surgery: a translational perspective on early esophageal cancer management. [PDF]

Front Med (Lausanne)
Pan MX, Sun LN, Su ML, Xiu YL.
europepmc   +1 more source

Blunt dissection for esophageal cancer.

, 1987
Hirotaka Sato, Kiyomi Suda, Isao Murayama, Takashi Tanaka, Takashi Sakabe   +4 more
openalex   +2 more sources

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

Cancer Communications, EarlyView.
Abstract Background Glecirasib, an inhibitor of Kirsten rat sarcoma viral oncogene homolog glycine‐to‐cysteine substitution at codon 12 (KRAS G12C), has exhibited clinical activity in non‐small‐cell lung cancer (NSCLC) and colorectal cancer (CRC).
Jian Li, Ting Deng, Yanhong Gu, Antonio Calles Blanco, Zhihua Li, Chunmei Bai, Lin Wu, Jing Huang, Xingya Li, Yu Yao, Zhengbo Song, Yongsheng Li, Lian Liu, Ligang Xing, Wenming Wu, Julia Martínez‐Pérez, Ayala Hubert, Jon Zugazagoitia, Jian Zhang, Yongsheng Wang, Yanqiu Zhao, Guilan Wen, Guohao Xia, Diansheng Zhong, Xueqin Chen, Kuirong Jiang, Andrea Wang‐Gillam, Yuli Ding, Sumei Liu, Zhiyue Rao, Xinghu Liu, Lin Shen   +31 more
wiley   +1 more source

The usefulness of immunonutrition in chemotherapy and chemoradiotherapy for esophageal cancer. [PDF]

Oncol Lett
Araki S, Araki T, Tanaka N, Sakai M, Nagamine A, Nagano D, Yashima H, Saeki H, Kuwano H, Yamamoto K.   +9 more
europepmc   +1 more source

Esophageal Cancer and Right Vocal Cord Paralysis

, 1984
Hideo Ishii, H Niibe, Yoshio Tamaki
openalex   +2 more sources

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

Cancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu, Yan Li, Bingjie Lian, Yitao Mao, Luqing Zhao   +4 more
wiley   +1 more source